Skip to content

Author

A. Al-Qahtani

We have 3 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

SARS-CoV-2 infection and two-year longitudinal clinical trajectory in pulmonary hypertension: a single-center retrospective exploratory cohort study

Introduction SARS-CoV-2 may promote endothelial injury, pulmonary vascular inflammation, and thrombosis, mechanisms relevant to pulmonary hypertension (PH), but longitudinal post-COVID-19 trajectories in established PH remain poorly defined. Methods We retrospectively analysed 40 PH patients in the prospectively establ...

A. Al-Qahtani, F. Alzubi, D. Obeid et al. · 0 citations
#protein folding Open access Sep 2026

Resveratrol enhances methotrexate-mediated suppression of inflammatory cytokines via NF-κB and MAPK pathway inhibition in THP-1 cells

Resveratrol enhances MTX’s anti-inflammatory effects via dual inhibition of NF-κB and MAPK pathways, while reducing MTX-induced toxicity, and support the potential of MTX-resveratrol co-therapy as a safer, more effective strategy for managing chronic inflammatory diseases.

Mashael J. Abu-Alola, Moonerah M. Alnasser, A. Al-Qahtani et al. · 0 citations
Open access Aug 2026

Diet supplementation with the macroalgae Laurencia glandulifera and Dictyopteris membranacea limits postprandial hyperglycemia and alters intestinal microbiome in mice

Background Development of obesity and type 2 diabetes largely depends on dietary habits that concomitantly affect the gut microbiome resulting in dysbiosis. Several dietary supplements have been suggested to suppress development of diabetes, partly via changes in the gut microbiome. Earlier research has shown that seco...

Maria G Daskalaki, A. Al-Qahtani, A. Tsoureki et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.